Literature DB >> 15857806

Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups.

Lena Svensson1, Christine Wennerås.   

Abstract

Eosinophils are predominantly found in tissues that have an interface with the external environment and its bacterial flora, such as the gastrointestinal and respiratory tracts. Although it is not the primary function of eosinophils to phagocytose and kill bacteria, we hypothesized that they might be able to recognize and become activated by microorganisms that enter the normally sterile tissues where they reside. The aim of this study was to evaluate whether human eosinophils get universally activated by bacteria or if they discriminate between bacteria derived from different phylogenetic groups. Eleven bacterial species representative of different taxonomic groups were examined. A hierarchy was seen among the bacterial species regarding their capacity to activate eosinophils. Furthermore, several eosinophilic activation patterns were evoked by the different bacterial species. The strongest eosinophil activator, Escherichia coli, elicited chemotaxis, degranulation and respiratory burst. Low numbers of bacteria caused the release of the granule proteins major basic protein and eosinophil peroxidase, whereas high numbers were required for the release of eosinophil cationic protein (ECP). Eosinophils did not seem to discriminate between gram-positive and gram-negative bacteria, unlike monocytes. However, the release of ECP was mainly seen after stimulation with gram-negative species. Blockade of the formyl peptide receptor partially inhibited bacterial activation of eosinophils, implicating its involvement in this activity. We propose that the presence of defined bacterial species in the normally sterile tissues inhabited by eosinophils may constitute danger signals to eosinophils. This may be of importance in the perpetuation of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857806     DOI: 10.1016/j.micinf.2005.01.010

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  25 in total

Review 1.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

2.  Hematological features in adolescents with periodontitis.

Authors:  Rodrigo López; Bruno G Loos; Vibeke Baelum
Journal:  Clin Oral Investig       Date:  2011-10-19       Impact factor: 3.573

3.  Antimicrobial Activity of Human Eosinophil Granule Proteins.

Authors:  Anu Chopra; Janendra K Batra
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

Review 5.  Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity?

Authors:  Praveen Akuthota; Jason J Xenakis; Peter F Weller
Journal:  J Innate Immun       Date:  2011       Impact factor: 7.349

Review 6.  The role of eosinophils in non-parasitic infections.

Authors:  Stefanie N Linch; Jeffrey A Gold
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2011-06       Impact factor: 2.895

Review 7.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

8.  Mouse eosinophils possess potent antibacterial properties in vivo.

Authors:  Stefanie N Linch; Ann M Kelly; Erin T Danielson; Ralph Pero; James J Lee; Jeffrey A Gold
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

Review 9.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

10.  Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis.

Authors:  J A Peña; L Thompson-Snipes; P R Calkins; N Tatevian; M Puppi; M J Finegold
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.